Diebold Nixdorf Inc (DBD)

Cost of Revenue

$2.86B

TTM · Period ending: · USD

DBD logo

DBD Cost of Revenue

Latest reported$2.86B
DBD TTM Cost of Revenue ($0.00 → $2.86B)
High-resolution chart · PNG

DBD cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Diebold Nixdorf Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
1,191,472,000
1,193,187,000
1,148,552,000
1,056,397,000
926,052,000
813,162,000
767,700,000
745,500,000
734,800,000
728,600,000
741,100,000
752,900,000
774,600,000
793,000,000
768,500,000
741,400,000
706,300,000
668,200,000
639,300,000
611,200,000
577,400,000
549,000,000
539,400,000
527,700,000
511,400,000
503,800,000
491,000,000
466,600,000
451,300,000
431,300,000
405,500,000
384,200,000
364,600,000
353,300,000
342,200,000
330,200,000
328,700,000
322,600,000
317,300,000
313,800,000
314,000,000
317,300,000
321,100,000
239,400,000
158,300,000
74,900,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.